Follow
Jan C. Grutters
Jan C. Grutters
Professor of Interstitial Lung Diseases
Verified email at antoniusziekenhuis.nl
Title
Cited by
Cited by
Year
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis
L Richeldi, RM Du Bois, G Raghu, A Azuma, KK Brown, U Costabel, ...
New England Journal of Medicine 370 (22), 2071-2082, 2014
34172014
Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial
SCA Meijvis, H Hardeman, HHF Remmelts, R Heijligenberg, GT Rijkers, ...
The Lancet 377 (9782), 2023-2030, 2011
3902011
The WASOG sarcoidosis organ assessment instrument: an update of a previous clinical tool
MA Judson, U Costabel, M Drent, A Wells, L Maier, L Koth, H Shigemitsu, ...
Sarcoidosis Vasculitis and diffuse Lung Diseases 31 (1), 19-27, 2014
3422014
Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study
SLF Walsh, AU Wells, SR Desai, V Poletti, S Piciucchi, A Dubini, H Nunes, ...
The lancet Respiratory medicine 4 (7), 557-565, 2016
3322016
Surfactant protein C mutations are the basis of a significant portion of adult familial pulmonary fibrosis in a dutch cohort
CHM van Moorsel, MFM van Oosterhout, NP Barlo, PA de Jong, ...
American journal of respiratory and critical care medicine 182 (11), 1419-1425, 2010
2632010
MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
PA Juge, JS Lee, E Ebstein, H Furukawa, E Dobrinskikh, S Gazal, ...
New England Journal of Medicine 379 (23), 2209-2219, 2018
2472018
Corticosteroid treatment in sarcoidosis
JC Grutters, JMM Van den Bosch
European Respiratory Journal 28 (3), 627-636, 2006
2172006
Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: a clinical evaluation
JC Grutters, JM Fellrath, L Mulder, R Janssen, JMM van den Bosch, ...
Chest 124 (1), 186-195, 2003
2162003
Methotrexate vs azathioprine in second-line therapy of sarcoidosis
ADM Vorselaars, WA Wuyts, VMM Vorselaars, P Zanen, VHM Deneer, ...
Chest 144 (3), 805-812, 2013
2072013
HLA-DQB1* 0201: a marker for good prognosis in British and Dutch patients with sarcoidosis
H Sato, JC Grutters, P Pantelidis, AN Mizzon, T Ahmad, AJ Van Houte, ...
American journal of respiratory cell and molecular biology 27 (4), 406-412, 2002
2052002
Nintedanib with add-on pirfenidone in idiopathic pulmonary fibrosis. Results of the INJOURNEY trial
C Vancheri, M Kreuter, L Richeldi, CJ Ryerson, D Valeyre, JC Grutters, ...
American journal of respiratory and critical care medicine 197 (3), 356-363, 2018
1862018
Increased frequency of the uncommon tumor necrosis factor− 857T allele in British and Dutch patients with sarcoidosis
JC Grutters, H Sato, P Pantelidis, AL Lagan, DS McGrath, JWJ Lammers, ...
American journal of respiratory and critical care medicine 165 (8), 1119-1124, 2002
1742002
Human neutrophils switch to an activated phenotype after homing to the lung irrespective of inflammatory disease
E Fortunati, KM Kazemier, JC Grutters, L Koenderman, ...
Clinical & Experimental Immunology 155 (3), 559-566, 2009
1492009
CC chemokine receptor 2 and sarcoidosis: association with Lofgren's syndrome
P Spagnolo, EA Renzoni, AU Wells, H Sato, JC Grutters, P Sestini, ...
American journal of respiratory and critical care medicine 168 (10), 1162-1166, 2003
1472003
New treatment strategies for pulmonary sarcoidosis: antimetabolites, biological drugs, and other treatment approaches
RP Baughman, JC Grutters
The Lancet Respiratory Medicine 3 (10), 813-822, 2015
1412015
Combination therapy: the future of management for idiopathic pulmonary fibrosis?
WA Wuyts, KM Antoniou, K Borensztajn, U Costabel, V Cottin, B Crestani, ...
The lancet Respiratory medicine 2 (11), 933-942, 2014
1402014
Systemic cytokine response in patients with community-acquired pneumonia
H Endeman, SCA Meijvis, GT Rijkers, H van Velzen–Blad, ...
European Respiratory Journal 37 (6), 1431-1438, 2011
1402011
Genetics of fibrosing lung diseases
JC Grutters, RM Du Bois
European Respiratory Journal 25 (5), 915-927, 2005
1372005
Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force
RP Baughman, S Nagai, M Balter, U Costabel, M Drent, R Du Bois, ...
Sarcoidosis vasc diffuse lung dis 28 (1), 56-64, 2011
1332011
Serum and BALF YKL-40 levels are predictors of survival in idiopathic pulmonary fibrosis
NM Korthagen, CHM van Moorsel, NP Barlo, HJT Ruven, A Kruit, M Heron, ...
Respiratory medicine 105 (1), 106-113, 2011
1292011
The system can't perform the operation now. Try again later.
Articles 1–20